Washington Trust Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Washington Trust Advisors's AMGN Position: Q2 2026 in Review
Washington Trust Advisors reduced its Amgen (AMGN) stake by 29% in Q2 2026, selling an estimated $111K and leaving 796 shares worth $288K. The position accounts for 0.02% of the portfolio, ranked #197.
Washington Trust Advisors first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $430K in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Washington Trust Advisors held 796 shares of Amgen worth $288K as of Q2 2026.
- Washington Trust Advisors sold 324 Amgen shares in Q2 2026, an estimated $111K.
- Amgen made up 0.02% of Washington Trust Advisors's portfolio in Q2 2026, its #197 holding.
- Washington Trust Advisors first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- Washington Trust Advisors's Amgen position peaked at $430K in Q3 2024.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.